ERBB2 and breast carcinoma: CCL5 is also significantly overexpressed in HER2+ breast cancer relative to luminal in METABRIC (p-value of 9 × 10−9) with a similar trend that failed to reach statistical significance in TCGA (p-value of 0.09).